Table 5.

Results of questionnaire evaluation of the use of the patient-reported outcome (PRO) diabetes tool by health care professionals (N=12)^a.

Item contentb		Mean single-item score (SD)
General dialog evaluation
	How would you rate the overall quality of the dialogue with this patient?	4.25 (1.1)
	Did you cover all the topics in the visit that were important to you from a clinical perspective?	4.4 (0.7)
Evaluation of influence of use of PRO
	How interested are you in using DiaProfil in its present form in your future diabetes consultations?	9.25 (1.0)
	How satisfied or dissatisfied were you overall with use of DiaProfil in the consultation?	4.6 (0.7)
	Was the person with diabetes was more or less prepared for your dialog due to answering the PRO questionnaire?	3.75 (0.75)
	Do you feel that your use of DiaProfil changed your role in the conversation?	3.5 (1.0)
	Did you experience that the person with diabetes got to speak more or less during this visit due to use of DiaProfil?	3.6 (0.5)
	Did DiaProfil make you aware of clinically relevant issues for this patient you were not aware of before?	2.67 (1.3)
	Did you experience challenges due to the use of DiaProfil during the visit?	2.33 (1.4)

^aMean single-item scores of health care professional evaluations of use of patient-reported outcome in the visit (PRO-CON-EVAL-P-1A-pilot).

^bScore range is 1-5. Score of 1-2: negative; 3: neutral; and 4-5: positive (except for the question on interest in continued use, which has a score range of 1-10).